SHEN26 (ATY014) is a potent, orally active RdRp inhibitor with an IC50 of 1.36 µM for SARS-CoV-2. As a 5-cyclohexanecarboxylate derivative of GS-441524, SHEN26 inhibits viral nucleic acid synthesis, achieving antiviral effects. SHEN26 can be used for COVID-19 research [1] [2].
Molecular Weight:
401.42
CAS Number:
[2691076-98-7]
Formula:
C19H23N5O5
Target:
SARS-CoV
T87387
* VAT and and shipping costs not included. Errors and price changes excepted
